Exogenous glutathione contributes to cisplatin resistance in lung cancer A549 cells (vol 10, pg 1295, 2018)

被引：0
|
作者：
Lan, Dong [1 ]
Wang, Li [2 ]
He, Rongquan [1 ]
Ma, Jie [1 ]
Bin, Yehong [1 ]
Chi, Xiaojv
Chen, Gang [3 ]
Cai, Zhengwen [2 ]
机构：
[1] Guangxi Med Univ, Affiliated Hosp 1, Dept Med Oncol, 6 Shuangyong Rd, Nanning 530021, Guangxi Zhuang, Peoples R China
[2] Guangxi Med Univ, Affiliated Hosp 2, Dept Med Oncol, 166 Daxuedong Rd, Nanning 530007, Guangxi Zhuang, Peoples R China
[3] Guangxi Med Univ, Affiliated Hosp 1, Dept Pathol, 6 Shuangyong Rd, Nanning 530021, Guangxi Zhuang, Peoples R China
来源：
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH | 2020年 / 12卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：308 / 309
页数：2
相关论文
共 50 条
  • [31] Alteration of membrane lipid biophysical properties and resistance of human lung adenocarcinoma A549 cells to cisplatin
    Liang, XJ
    Huang, YG
    SCIENCE IN CHINA SERIES C-LIFE SCIENCES, 2001, 44 (01): : 25 - 32
  • [32] MLKL-PITPα, signaling-mediated necroptosis contributes to cisplatin-triggered cell death in lung cancer A549 cells
    Jing, Lin
    Song, Fei
    Liu, Zhenyu
    Li, Jianghua
    Wu, Bo
    Fu, Zhiguang
    Jiang, Jianli
    Chen, Zhinan
    CANCER LETTERS, 2018, 414 : 136 - 146
  • [33] Regulation of cytotoxicity and apoptosis-associated pathways contributes to the enhancement of efficacy of cisplatin by baicalein adjuvant in human A549 lung cancer cells
    Kiartivich, Suparata
    Wei, Ying
    Liu, Jiaqi
    Soiampornkul, Rungtip
    Li, Mihui
    Zhang, Hongying
    Dong, Jingcheng
    ONCOLOGY LETTERS, 2017, 13 (04) : 2799 - 2804
  • [34] Periostin Contributes to Cisplatin Resistance in Human Non-Small Cell Lung Cancer A549 Cells via Activation of Stat3 and Akt and Upregulation of Survivin
    Hu, Wenxia
    Jin, Pule
    Liu, Wei
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2016, 38 (03) : 1199 - 1208
  • [35] Survivin expression modulates the sensitivity of A549 lung cancer cells resistance to vincristine
    Zhou, Chengwei
    Zhu, Yonggang
    Lu, Bin
    Zhao, Weijun
    Zhao, Xiaodong
    ONCOLOGY LETTERS, 2018, 16 (04) : 5466 - 5472
  • [36] RETRACTION: Implication of BIS in the Migration and Invasion of A549 Non-small Cell Lung Cancer Cells (Retraction of Vol 38, Pg 5057, 2018)
    Yun, Hye Hyeon
    Kim, Seulki
    Ji, Sang Hee
    Kuh, Hyo-Jeong
    Lee, Jeong-Hwa
    ANTICANCER RESEARCH, 2018, 38 (10) : 6027 - 6027
  • [37] Investigating the role of let-7a microRNA in cisplatin sensitivity of A549 lung cancer cells
    Aslan, Elif Sibel
    Aydin, Ece
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 (06) : 3979 - 3984
  • [38] Cytoskeletal changes during cellular response of the A549 lung cancer cells to continuous cisplatin treatment
    Szczepanski, Mariusz Andrzej
    Grzanka, Aline
    Litwiniec, Anna
    Gackowska, Lidia
    Kubiszewska, Izabela
    Grzanka, Dariusz
    CELL BIOLOGY INTERNATIONAL, 2010, 34 (02) : 197 - 211
  • [39] The long noncoding RNA ANRIL acts as an oncogene and contributes to paclitaxel resistance of lung adenocarcinoma A549 cells
    Xu, Ran
    Mao, Yuqiang
    Chen, Kuanbing
    He, Wei
    Shi, Wenjun
    Han, Yun
    ONCOTARGET, 2017, 8 (24) : 39177 - 39184
  • [40] Reversal effect of adenovirus-mediated human interleukin 24 transfection on the cisplatin resistance of A549/DDP lung cancer cells
    Xu, Mingju
    Tang, Xioawei
    Guo, Jinjin
    Sun, Wangbang
    Tang, Faqing
    ONCOLOGY REPORTS, 2017, 38 (05) : 2843 - 2851
12345